Wednesday, May 8, 2013

Baxter Can Bounce Back



See on Scoop.it - Alzheimer's and Dementia


A failed Alzheimer's trial is pressuring the drug and medical-device company's stock, but we expect shares to recover.

See on online.barrons.com